TORONTO, Feb. 16 /CNW/ - Jamieson Laboratories has solidified its position as an international leader in the natural supplements market, effectively doubling its sales in China overnight by acquiring expanded distribution in China's leading health and beauty chain. An aggressive push for greater distribution and a clear focus on international expansion gives Jamieson Laboratories, Canada's leading natural health care company, a significant position of strength in the Chinese market. "
Our vision for the Chinese market is to continue our efforts on increased distribution with China's leading retailers," said Bill Tyler, Vice President, Sales, Jamieson Laboratories. "The expectation for Jamieson Laboratories is a significant increase in awareness and in sales of our products in Asian markets over the next year."
Jamieson products are sold along-side major world-class luxury brands in the leading retail outlets and shopping centres, such as the Lufthansa Centre in Beijing. In the past three years, Jamieson's sales have increased by more than 400 per cent in the Chinese market. This significant lift has been fuelled by aggressive sales targets, increased distribution and Jamieson's premium positioning in the Chinese marketplace, which sees its products positioned in the same category as luxury retail brands.
Established in 1922, Jamieson Laboratories is Canada's largest manufacturer and distributor of advanced natural health-care products. Jamieson's state-of-the-art pharmaceutical manufacturing laboratories are located in Windsor, Ontario and Quest's manufacturing facilities in Vancouver, British Columbia. The company is a world leader in the vitamin and nutrition industry, exporting to over 30 countries including the USA, China, Japan, Hong Kong, Korea and Singapore. For more information, please visit the Jamieson Laboratories Web site at www.jamiesonvitamins.com.
Canadas Jamieson Laboratories doubles its distribution at Chinas leading upscale health and beauty chain
信息来源:Canada NewsWire 更新时间:2006-2-20 22:10:25
产业频道录入:admin 责任编辑:admin
栏目精选
相关文章
CytoDyn Signs On for Joint Venture in China and Gl
Chinas Star Pharmaceutical Makes Strong Debut On S
China to handle Pfizers lawsuit for Viagras patent
China Northwest Biotech Signs Distribution Agreeme
Medicine giant plans big rise in China sales
China Worldbest to Spin off Pharma Assets to China
China Northwest Biotech to Begin Trading Under New
Bodisen Biotech to Present at the Roth Capital Par
Clinical trials activity heats up in China
Mid-term examination launched for Malaysian dumpin
Chinas Star Pharmaceutical Makes Strong Debut On S
China to handle Pfizers lawsuit for Viagras patent
China Northwest Biotech Signs Distribution Agreeme
Medicine giant plans big rise in China sales
China Worldbest to Spin off Pharma Assets to China
China Northwest Biotech to Begin Trading Under New
Bodisen Biotech to Present at the Roth Capital Par
Clinical trials activity heats up in China
Mid-term examination launched for Malaysian dumpin
文章评论(评论内容只代表网友观点,与生物谷立场无关!)
推荐产品
最新资讯
热点聚焦
推荐文章


